Chromatin Remodeling INO80 Complex as Targeted Therapeutics Platform in Hematologic Malignancies 2023 PARTNERSHIP WITH GABRIELLE'S ANGEL FOUNDATION FOR CANCER RESEARCH David Dominguez-Sola, MD, PhD, Icahn School of Medicine at Mount Sinai-Tisch Cancer Institute; Daniel Herranz-Benito, PharmD, PhD, Rutgers Cancer Institute of New Jersey Read More
Mechanisms of Cellular Response to Errors in Mitosis: a New, non-Genetic Approach to an Old Question 2023 PARTNERSHIP WITH THE EUROPEAN ASSOCIATION FOR CANCER RESEARCH AND THE PEZCOLLER FOUNDATION Stamatis Papathanasiou, PhD, The Institute of Molecular Biology Read More
Tumor Promotion and Protection 2023 ASPIRE II Award Charles Swanton, MBPhD, FRCP, FMedSci, FAACR, FRS, The Francis Crick Institute (United Kingdom); Sherene Loi, MD, PhD, Division of Cancer Research, The Sir Peter MacCallum Department of Oncology/University of Melbourne (Australia) Read More
Personalized T Cell-Directed Cancer Immunotherapy 2023 Endeavor Award Dana-Farber Cancer Institute: Catherine Wu, MD • The Broad Institute: Nir Hacohen, PhD; Fei Chen, PhD Read More
Inflammatory Drivers of The Obesity-Cancer Connection 2023 Endeavor Award Jeffrey Rathmell, PhD, University of Chicago; Alyssa Hasty, PhD, Vanderbilt University; Kathryn Wellen, PhD, The University of Pennsylvania; Liza Makowski, PhD, University of Tennessee Health Sciences Center Read More
Harnessing Senescence Biology for Immune Oncology 2023 Endeavor Award Memorial Sloan Kettering Cancer Center: Scott Lowe, PhD; Paul Romesser, MD; Michel Sadelain, MD, PhD; Julio Garcia-Aguilar, MD; Andrea Schietinger, PhD; Dana Pe’er, PhD Read More
